Astragaloside IV and tumor microenvironmental barriers: immune mechanisms, evidence hierarchy, and implications for checkpoint blockade

Yingbo Wang, Mingyao Liu, Liping Zhong

Open source

DOI
10.3389/fimmu.2026.1991297
Published
2026-10-22
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1991297,
  title = {Astragaloside IV and tumor microenvironmental barriers: immune mechanisms, evidence hierarchy, and implications for checkpoint blockade},
  author = {Yingbo Wang and Mingyao Liu and Liping Zhong},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1991297},
  url = {https://doi.org/10.3389/fimmu.2026.1991297}
}

RIS

TY  - JOUR
TI  - Astragaloside IV and tumor microenvironmental barriers: immune mechanisms, evidence hierarchy, and implications for checkpoint blockade
AU  - Yingbo Wang
AU  - Mingyao Liu
AU  - Liping Zhong
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1991297
UR  - https://doi.org/10.3389/fimmu.2026.1991297
ER  - 

APA

Wang, Y., Liu, M., & Zhong, L. (2026). Astragaloside IV and tumor microenvironmental barriers: immune mechanisms, evidence hierarchy, and implications for checkpoint blockade. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1991297

Source records